FindTrial
Sign In

Pipelle endometrial sampling method versus dilatation and curettage in patients with abnormal uterine bleeding

Pipelle Endometrial Sampling Versus Dilatation And Curettage In Patients With Abnormal Uterine Bleeding: A Hospital Based Comparative Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/12/060764
Enrollment
156
Registered
2023-12-26
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified Health Condition 2: N850- Endometrial hyperplasia Health Condition 3: N921- Excessive and frequent menstruation with irregular cycle Health Condition 4: N920- Excessive and frequent menstruation with regular cycle Health Condition 5: N924- Excessive bleeding in the premenopausal period Health Condition 6: N922- Excessive menstruation at puberty Health Condition 7: N926- Irregular menstruation, unspecified Health Conditi

Interventions

Intervention1: Dilatation and Curettage: Dilatation and Curettage will be performed under anaesthesia in which a curette, which is a thin, spoon-shaped instrument, will be inserted into the uterus to

Sponsors

Government Medical College, Haldwani
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients willing to participate 2. Women of reproductive age group with abnormal uterine bleeding 3. Perimenopausal and postmenopausal females with AUB

Exclusion criteria

Exclusion criteria: 1. Uncooperative patients or patients not willing to participate 2. PID or other reproductive tract infections 3. Endometrial thickness less than or equal to 4mm or history of uterine perforation 4. Structural defects of uterus such as bicornuate or septate uterus 5. Focal uterine pathologies such as fibroid or polyp 6. Women with persistent intermenstrual or persistent irregular bleeding, and women with infrequent heavy bleeding who are obese or have polycystic ovary syndrome 7. Pregnancy 8. Women with breast cancer on tamoxifen 9. Women for whom treatment for Heavy Menstrual Bleeding has been unsuccessful

Design outcomes

Primary

MeasureTime frame
To compare the diagnostic accuracy of pipelle endometrial sampling and dilatation and curettage.Timepoint: at baseline and at 4 weeks—

Secondary

MeasureTime frame
To compare the complications of pipelle endometrial sampling & dilatation & curettageTimepoint: at baseline & at 4 weeks—

Countries

India

Contacts

Public ContactDr Geeta Jain

Government Medical College, Haldwani

ikneiv@hotmail.com9412905449

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026